Exclusive

Publication

Byline

US Patent Issued to IMPERIAL COLLEGE INNOVATIONS, MYRICX PHARMA on May 26 for "Imidazo[1,2-apyridine compounds and their use in therapy" (British, Swiss Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,637,458, issued on May 26, was assigned to IMPERIAL COLLEGE INNOVATIONS Ltd. (London) and MYRICX PHARMA Ltd. (London). "Imidazo[1,2-apyridine co... Read More


US Patent Issued to TAPI CZECH INDUSTRIES S.R.O on May 26 for "Solid state forms of Lorecivivint" (Czech Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,637,459, issued on May 26, was assigned to TAPI CZECH INDUSTRIES S.R.O (Opava-komarov, Czech Republic). "Solid state forms of Lorecivivint" was ... Read More


US Patent Issued to LG DISPLAY on May 26 for "Organic compound, and organic light emitting diode and organic light emitting display device including the same" (South Korean Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,637,460, issued on May 26, was assigned to LG DISPLAY Co. LTD. (Seoul, South Korea). "Organic compound, and organic light emitting diode and org... Read More


US Patent Issued to Pfizer on May 26 for "Compounds for the activation of AMPK" (American, German Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,637,461, issued on May 26, was assigned to Pfizer Inc. (New York). "Compounds for the activation of AMPK" was invented by Gary Erik Aspnes (Bibe... Read More


US Patent Issued to Pliant Therapeutics on May 26 for "Integrin inhibitor and uses thereof" (California, New Jersey Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,637,462, issued on May 26, was assigned to Pliant Therapeutics Inc. (South San Francisco, Calif.). "Integrin inhibitor and uses thereof" was inv... Read More


US Patent Issued to DANA-FARBER CANCER INSTITUTE on May 26 for "Tricyclic kinase inhibitors and uses thereof" (Massachusetts, California, Illinois Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,637,463, issued on May 26, was assigned to DANA-FARBER CANCER INSTITUTE INC. (Boston). "Tricyclic kinase inhibitors and uses thereof" was invent... Read More


US Patent Issued to The Regents of the University of California on May 26 for "Tetracyclic compounds for treating brain disorders" (California Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,637,464, issued on May 26, was assigned to The Regents of the University of California (Oakland, Calif.). "Tetracyclic compounds for treating br... Read More


US Patent Issued to PTC Therapeutics MP on May 26 for "Pharmaceutically acceptable salts of sepiapterin" (American, Japanese Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,637,465, issued on May 26, was assigned to PTC Therapeutics MP Inc. (Warren, N.J.). "Pharmaceutically acceptable salts of sepiapterin" was inven... Read More


US Patent Issued to LG CHEM on May 26 for "Benzocarbazole-based compound and organic light-emitting device comprising same" (South Korean Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,637,466, issued on May 26, was assigned to LG CHEM Ltd. (Seoul, South Korea). "Benzocarbazole-based compound and organic light-emitting device c... Read More


US Patent Issued to Newave Pharmaceutical on May 26 for "Inhibitor of BTK and mutants thereof" (California Inventor)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,637,467, issued on May 26, was assigned to Newave Pharmaceutical Inc. (Pleasanton, Calif.). "Inhibitor of BTK and mutants thereof" was invented ... Read More